NL-OMON25681招募中不适用
Cost-effectiveness of subcutaneous immunotherapy in adults with allergic rhinitis.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Erasmus MC
- 入组人数
- 240
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. 18-45 years;
- •2. Clinically relevant moderate to severe allergic rhinitis due to a sensitization for one, two or three of the following
- •allergens: tree pollen (TP), grass pollen (GP) and/or house dust mite (HDM). For each allergen (TP, GP, HDM) the following 3 criteria are evaluated. A sensitization for an allergen is considered clinically relevant and the rhinitis moderate-severe if:
排除标准
- •1. Severe/instable asthma:
- •A. FEV1 <70% predicted and/or FEV1/FVC <70;
研究者
相似试验
进行中（未招募）
不适用
Cost-effectiveness of subcutaneous immunotherapy in adults with allergic rhinitis. - Cost-effectiveness of SCIT in allergic rhinitisEUCTR2009-011827-30-NLErasmusMC-University Medical Center Rotterdam
已完成
4 期
Cost-effectiveness of subcutaneous immunotherapy in adults with allergic rhinitis10001708allergic rhinitishay feverNL-OMON37299Erasmus MC, Universitair Medisch Centrum Rotterdam240
Unknown
2 期
Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.Pulmonary Alveolar ProteinosisNCT01983657Shanghai Pulmonary Hospital, Shanghai, China40
已完成
4 期
SubCutaneous Immunotherapy Treatment Effect (CITE) studyallergic rhinitishayfever10001708NL-OMON36931Erasmus MC, Universitair Medisch Centrum Rotterdam80
进行中（未招募）
不适用
A Phase I/II Study of Immunotherapy with Subcutaneous Administered Veltuzumab (hA20) in Patients with CD20+ Non-Hodgkin's Lymphoma or Chronic Lyphocytic LeukemiaEUCTR2008-000434-47-FRImmunomedics, Inc.46